SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Bolt Thomas Allen

(Last) (First) (Middle)
C/O AMERICAN INTERNATIONAL GROUP, INC.
1271 AVE OF THE AMERICAS

(Street)
NEW YORK NY 10020-1304

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/12/2022
3. Issuer Name and Ticker or Trading Symbol
AMERICAN INTERNATIONAL GROUP, INC. [ AIG ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and Chief Risk Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 26,878 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
2018 Stock Option (Right to Buy) 01/01/2021 03/13/2028 Common Stock 20,903 $55.94 D
2019 Stock Option (Right to Buy) 01/01/2022 03/18/2029 Common Stock 30,712 $44.28 D
2020 Restricted Stock Units (1) (1) Common Stock 30,286 (2) D
2020 Stock Option (Right to Buy) 01/01/2023 03/11/2030 Common Stock 35,087 $32.43 D
2021 Restricted Stock Units (3) (3) Common Stock 17,730 (2) D
2021 Stock Options (Right to Buy) 01/01/2024 02/22/2031 Common Stock 21,367 $44.1 D
2022 Restricted Stock Units (4) (4) Common Stock 8,256 (2) D
2022 Stock Options (Right to Buy) (5) 02/22/2032 Common Stock 15,197 $61.61 D
Explanation of Responses:
1. The 2020 Restricted Stock Units (2020 RSUs) vest on January 1, 2023, subject to the reporting person's continued employment through the vesting date, and such 2020 RSUs are settled in shares of AIG Common Stock.
2. The 2020 RSUs, 2021 Restricted Stock Units (2021 RSUs) and 2022 Restricted Stock Units (2022 RSUs) convert to AIG Common Stock on a 1-to-1 basis.
3. The 2021 RSUs vest on January 1, 2024, subject to the reporting person's continued employment through the vesting date, and such 2021 RSUs are settled in shares of AIG Common Stock.
4. One third of the 2022 RSUs vests on each of the first, second and third anniversaries of the grant date, February 22, 2022, subject to the reporting person's continued employment through each applicable vesting date, and such 2022 RSUs are settled in shares of AIG Common Stock.
5. One third of the 2022 Stock Options vests on each of the first, second and third anniversaries of the grant date, February 22, 2022, subject to the reporting person's continued employment through each applicable vesting date.
Remarks:
poathomasbolt.txt
/s/ Alanna Franco, attorney-in-fact 04/22/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.